RecAP: Phase II started

AM-Pharma began the double-blind, placebo-controlled, international Phase II STOP-AKI trial to evaluate

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE